← All companies

PRME

Prime Medicine, Inc.

PRME Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.81

-0.21 -6.95%

Key statistics

from XBRL data in SEC filings

Market cap

$508M

Revenue (TTM)

$4.63M

Net income (TTM)

-$198M

EPS (TTM)

$-1.23

P/E ratio

—

Dividend yield

—

Free cash flow

-$167M

Cash

$64.1M

Total assets

$295M

Gross margin

—

52-week range

$2.67 – $6.94

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 8, 2026 8-K Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 3, 2026 8-K Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Regulation FD disclosure Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Aug 5, 2025 8-K Entered a material agreement Jul 31, 2025 8-K Results of operations (earnings release); Other events Jul 30, 2025 8-K Director or officer change Jul 15, 2025 8-K Shareholder vote results Jun 5, 2025 8-K Director or officer change; Regulation FD disclosure; Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Regulation FD disclosure; Other events Mar 18, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 28, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure Oct 24, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 12, 2024 8-K Amended charter or bylaws May 21, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 10, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Results of operations (earnings release) Mar 1, 2024 8-K Entered a material agreement Feb 16, 2024 8-K Results of operations (earnings release) Feb 14, 2024 8-K Regulation FD disclosure Jan 8, 2024